Pregabalin Addiction: Case Report of a Young Adult

  • Nitin Chaudhary
  • Sapna Jain
Keywords: Pregabalin, Addiction, Abuse, Dependence

Abstract

Pregabalin has been used widely for the treatment of neuropathic pain, generalized anxiety disorders and epilepsy. Data is scarce and much is not known about the addictive potential of pregabalin. Herein, we report details of a young adult who got addicted to pregabalin and approached for a smooth withdrawal. The subject had a successful outcome. Literature suggests a growing concern for the abuse of pregabalin. Risk factors associated with the development of addictive behavior with pregabalin need to be assessed.

Downloads

Download data is not yet available.

Author Biographies

Nitin Chaudhary

MD (Medicine), Private Practitioner and Consultant Doctor, Bhopal, India

Sapna Jain

MBBS, Private Practitioner, Smiles Multispeciality Clinic, Bhatinda, India

References

Martinotti G, Lupi M, Sarchione F, et al. The potential of pregabalin in neurology, psychiatry and addiction: a qualitative overview. Curr Pharm Des 2013;19(35):6367–74.

Pexton T, Moeller-Bertram T, Schilling JM, et al. Targeting voltage-gated calcium channels for the treatment of neuropathic pain: a review of drug development. Expert Opin Investig Drugs 2011;20(9):1277–84.

Wettermark B, Brandt L, Kieler H, et al. Pregabalin is increasingly prescribed for neuropathic pain, generalised anxiety disorder and epilepsy but many patients discontinue treatment. Int J Clin Pract 2014;68(1):104–10.

Cho YW, Song ML. Effects of pregabalin in patients with hypnotic-dependent insomnia. J Clin Sleep Med 2014;10(5):545–50.

Di Nicola M, Tedeschi D, Martinotti G, et al. Pregabalin augmentation in treatment-resistant obsessive-compulsive disorder: a 16-week case series. J Clin Psychopharmacol 2011;31(5):675–7.

Strawn JR, Dowling BP, Geracioti Jr TD. Pregabalin treatment of posttraumatic stress disorder. J Clin Psychopharmacol 2008;28(5):596–7.

Pae CU. Pregabalin augmentation to antidepressants in patients with major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2009;33(3):577–8.

Schönfeldt-Lecuona C, Wolf RC, Osterfeld ND, et al. Pregabalin in the treatment of schizophrenic anxiety. Pharmacopsychiatry 2009;42(3):124–5.

Oulis P, Kalogerakou S, Anyfandi E, et al. Cognitive effects of pregabalin in the treatment of long-term benzodiazepine-use and dependence. Hum Psycho-pharmacol 2014;29(3):224–9.

Biermann T, Bleich S, Kornhuber J, et al. Pregabalin in benzodiazepine withdrawal. Pharmacopsychiatry 2007;40(6):292–3.

Martinotti G, Di Nicola M, Tedeschi D, et al. Efficacy and safety of pregabalin in alcohol dependence. Adv Ther 2008;25(6):608–18.

Krupitsky EM, Ilyuk RD, Mikhailov AD, et al. A randomised single blind study of the efficacy of pregabalin in the treatment of opioid withdrawal syndrome. Zh Nevrol Psikhiatr Im SS Korsakova 2016;116(7):29–36.

Kämmerer N, Lemenager T, Grosshans M, et al. Pregabalin for the reduction of opiate withdrawal symptoms. Psychiatr Prax 2012;39(7):351–2.

Schwan S, Sundström A, Stjernberg E, et al. A signal for an abuse liability for pregabalin–results from the Swedish spontaneous adverse drug reaction reporting system. Eur J Clin Pharmacol 2010;66(9):947–53.

Spence D. Bad medicine: gabapentin and pregabalin. BMJ 2013;347:f6747.

Gabapentine, prégabaline : abus et dépendances. Rev Prescrire2012;32(340):116–8.

Prégabaline: suicides. Rev Prescrire 2019;39(434):911.

Halaby A, Kassm SA, Naja WJ. Pregabalin dependence: a case report. Curr Drug Saf 2015;10(2):184–6.

Skopp G, Zimmer G. Pregabalin–a drug with abuse potential? Arch Kriminol 2012;229(1–2):44–54.

Carrus D, Schifano F. Pregabalin misuse-related issues; intake of large dosages, drug-smoking allegations, and possible association with myositis: two case reports. J Clin Psychopharmacol 2012;32:839–40.

Muquebil A, Al Shaban Rodríguez W, Álvarez G. Abuso de pregabalina enpaciente de perfil impulsivo: tratamiento con topiramato. Psiquiatr Biológica2016;23(2):74–6.

Grosshans M, Lemenager T, Vollmert C, et al. Pregabalin abuse among opiate addicted patients. Eur J Clin Pharmacol 2013;69(12):2021–5.

Schifano F, D’Offizi S, Piccione M, et al. Is there a recreational misuse potential for pregabalin? Analysis of anecdotal online reports in comparison with related gabapentin and clonazepam data. Psychother Psychosom 2011;80(2):118–22.

Schifano F. Misuse and abuse of pregabalin and gabapentin: cause for concern? CNS Drugs 2014;28:491–6.

Bockbrader HN, Burger P, Knapp L. Pregabalin effect on steady-state pharmaco-kinetics of carbamazepine, lamotrigine, phenobarbital, phenytoin, topiramate, valproate, and tiagabine. Epilepsia 2011;52(2):405–9.

Bastiaens L, Galus J, Mazur C. Abuse of gabapentin is associated with opioid addiction. Psychiatr Q 2016;87(4):763–7.

Gahr M, Freudenmann RW, Hiemke C, et al. Pregabalin abuse and dependence in Germany: results from a database query. Eur J Clin Pharmacol 2013;69(6):1335–42.

Published
2020-06-20
How to Cite
Nitin Chaudhary, & Sapna Jain. (2020). Pregabalin Addiction: Case Report of a Young Adult. International Healthcare Research Journal, 4(3), 60-63. https://doi.org/10.26440/IHRJ/0403.06172